Home

formal Trickle Altitude annkristin heine nap Missing Pounding

Volume 21, Issue 3, Pages (October 2017) - ppt download
Volume 21, Issue 3, Pages (October 2017) - ppt download

ONLINE Cluster Lecture Series
ONLINE Cluster Lecture Series

Auszeichnung für herausragende Krebsforscher - Centrum für Integrierte  Onkologie
Auszeichnung für herausragende Krebsforscher - Centrum für Integrierte Onkologie

UKB NewsRoom | Annkristin Heine
UKB NewsRoom | Annkristin Heine

Immunotherapy as an advance in cancer medicine - Innovations Report
Immunotherapy as an advance in cancer medicine - Innovations Report

Total marrow irradiation versus total body irradiation using  intensity-modulated helical tomotherapy,Journal of Cancer Research and  Clinical Oncology - X-MOL
Total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy,Journal of Cancer Research and Clinical Oncology - X-MOL

CIO Bonn - Lymphomzentrum
CIO Bonn - Lymphomzentrum

Pacritinib protects dendritic cells more efficiently than ruxolitinib -  Experimental Hematology
Pacritinib protects dendritic cells more efficiently than ruxolitinib - Experimental Hematology

Team | IMMEI
Team | IMMEI

Clinical and immunological effects of mRNA vaccines in malignant diseases |  Molecular Cancer | Full Text
Clinical and immunological effects of mRNA vaccines in malignant diseases | Molecular Cancer | Full Text

Cardiac MRI Depicts Immune Checkpoint Inhibitor–induced Myocarditis: A  Prospective Study
Cardiac MRI Depicts Immune Checkpoint Inhibitor–induced Myocarditis: A Prospective Study

Bjørn Heine Strand - NIPH
Bjørn Heine Strand - NIPH

Dexamethasone induced inhibition of Dectin-1 activation of antigen  presenting cells is mediated via STAT-3 and NF-κB signaling pathways |  Scientific Reports
Dexamethasone induced inhibition of Dectin-1 activation of antigen presenting cells is mediated via STAT-3 and NF-κB signaling pathways | Scientific Reports

Unter der Leitung von Frau Prof.... - Krebszentrum CIO Bonn | Facebook
Unter der Leitung von Frau Prof.... - Krebszentrum CIO Bonn | Facebook

Ann-Kristin Müller – Stellvertretende Niederlassungsleiterin – Heine +  Beisswenger Gruppe | LinkedIn
Ann-Kristin Müller – Stellvertretende Niederlassungsleiterin – Heine + Beisswenger Gruppe | LinkedIn

AG Heine - Hämatologie und Onkologie des Universitätsklinikums Bonn
AG Heine - Hämatologie und Onkologie des Universitätsklinikums Bonn

Generation and functional characterization of MDSC-like cells
Generation and functional characterization of MDSC-like cells

Detection of Damaged DNA Bases by DNA Glycosylase Enzymes | Biochemistry
Detection of Damaged DNA Bases by DNA Glycosylase Enzymes | Biochemistry

UKB NewsRoom | Erfolg bei Ausschreibung „Advanced Clinician Scientist“
UKB NewsRoom | Erfolg bei Ausschreibung „Advanced Clinician Scientist“

Annkristin HEINE | Medical Doctor | Professor | University of Bonn -  Medical Center, Bonn | Haematology Oncology | Research profile
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile

PDF) Long-term survival after vaccination with RNA coding for TAA in Renal  Cell Carcinoma: update on survival and correlation with immunological  response
PDF) Long-term survival after vaccination with RNA coding for TAA in Renal Cell Carcinoma: update on survival and correlation with immunological response

Long-term survival correlates with immunological responses in renal cell  carcinoma patients treated with mRNA-based immunotherap
Long-term survival correlates with immunological responses in renal cell carcinoma patients treated with mRNA-based immunotherap

Researchers release the brakes on the immune | EurekAlert!
Researchers release the brakes on the immune | EurekAlert!

Frontiers | Case report: Complete response to pembrolizumab in a liver  metastatic colon adenocarcinoma patient with a novel likely pathogenic  germline MSH2 mutation
Frontiers | Case report: Complete response to pembrolizumab in a liver metastatic colon adenocarcinoma patient with a novel likely pathogenic germline MSH2 mutation